Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Home infusion therapy industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Regional trends
Chapter 3 Home Infusion Therapy Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing hospital acquired infections
3.3.1.2 Rising prevalence of chronic diseases
3.3.1.3 Advancements in technology
3.3.1.4 Growing geriatric population
3.3.1.5 Increasing preference towards at-home healthcare solutions
3.3.2 Industry pitfalls & challenges
3.3.2.1 Dearth of reimbursement
3.3.2.2 Safety concerns and risk of failure associated with home infusion devices
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.5 COVID- 19 impact analysis
3.6 Trends in home infusion therapy industry
3.7 Future prospects for home infusion therapy industry
3.8 Regulatory landscape
3.8.1 U.S.
3.8.2 Europe
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Home Infusion Therapy Market, By Product
5.1 Key segment trends
5.2 Infusion pumps
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Intravenous sets
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 IV Cannulas
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Needleless connectors
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Home Infusion Therapy Market, By Application
6.1 Key segment trends
6.2 Anti-infective
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Hydration therapy
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Chemotherapy
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Enteral nutrition
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Parenteral nutrition
6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Specialty pharmaceuticals
6.7.1 Market size, by region, 2018 - 2032 (USD Million)
6.8 Others
6.8.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Home Infusion Therapy Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2018 - 2032 (USD Million)
7.2.2 Market size, by product, 2018 - 2032 (USD Million)
7.2.3 Market size, by application, 2018 - 2032 (USD Million)
7.2.4 U.S.
7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.2.4.2 Market size, by application, 2018 - 2032 (USD Million)
7.2.5 Canada
7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.2 Market size, by product, 2018 - 2032 (USD Million)
7.3.3 Market size, by application, 2018 - 2032 (USD Million)
7.3.4 Germany
7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.4.2 Market size, by application, 2018 - 2032 (USD Million)
7.3.5 UK
7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
7.3.6 France
7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
7.3.7 Spain
7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.8.2 Market size, by application, 2018 - 2032 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.2 Market size, by product, 2018 - 2032 (USD Million)
7.4.3 Market size, by application, 2018 - 2032 (USD Million)
7.4.4 China
7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.4.2 Market size, by application, 2018 - 2032 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
7.4.6 India
7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
7.4.7 Australia
7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
7.4.8 South Korea
7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.5.2 Market size, by product, 2018 - 2032 (USD Million)
7.5.3 Market size, by application, 2018 - 2032 (USD Million)
7.5.4 Brazil
7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.5.4.2 Market size, by application, 2018 - 2032 (USD Million)
7.5.5 Mexico
7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
7.6 MEA
7.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.6.2 Market size, by product, 2018 - 2032 (USD Million)
7.6.3 Market size, by application, 2018 - 2032 (USD Million)
7.6.4 South Africa
7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.6.4.2 Market size, by application, 2018 - 2032 (USD Million)
Chapter 8 Company Profiles
8.1 B. Braun Melsungen AG
8.1.1 Business Overview
8.1.2 Financial Data
8.1.3 Product Landscape
8.1.4 Strategic Outlook
8.1.5 SWOT Analysis
8.2 Baxter International Inc.
8.2.1 Business Overview
8.2.2 Financial Data
8.2.3 Product Landscape
8.2.4 Strategic Outlook
8.2.5 SWOT Analysis
8.3 Becton Dickinson and Company
8.3.1 Business Overview
8.3.2 Financial Data
8.3.3 Product Landscape
8.3.4 Strategic Outlook
8.3.5 SWOT Analysis
8.4 Fresenius Kabi
8.4.1 Business Overview
8.4.2 Financial Data
8.4.3 Product Landscape
8.4.4 Strategic Outlook
8.4.5 SWOT Analysis
8.5 ICU Medical Inc.
8.5.1 Business Overview
8.5.2 Financial Data
8.5.3 Product Landscape
8.5.4 Strategic Outlook
8.5.5 SWOT Analysis
8.6 Terumo Corporation
8.6.1 Business Overview
8.6.2 Financial Data
8.6.3 Product Landscape
8.6.4 Strategic Outlook
8.6.5 SWOT Analysis
8.7 Moog Inc.
8.7.1 Business Overview
8.7.2 Financial Data
8.7.3 Product Landscape
8.7.4 Strategic Outlook
8.7.5 SWOT Analysis
8.8 Halyard Health, Inc. (Avanos Medical)
8.8.1 Business Overview
8.8.2 Financial Data
8.8.3 Product Landscape
8.8.4 Strategic Outlook
8.8.5 SWOT Analysis
8.9 Amsino International, Inc.
8.9.1 Business Overview
8.9.2 Financial Data
8.9.3 Product Landscape
8.9.4 Strategic Outlook
8.9.5 SWOT Analysis
8.10 Lepu Medical Technology
8.10.1 Business Overview
8.10.2 Financial Data
8.10.3 Product Landscape
8.10.4 Strategic Outlook
8.10.5 SWOT Analysis
8.11 Erenler Medikal
8.11.1 Business Overview
8.11.2 Financial Data
8.11.3 Product Landscape
8.11.4 Strategic Outlook
8.11.5 SWOT Analysis
8.12 Contec Medical Systems Co. Ltd
8.12.1 Business Overview
8.12.2 Financial Data
8.12.3 Product Landscape
8.12.4 Strategic Outlook
8.12.5 SWOT Analysis
8.13 JMS Co. Ltd.
8.13.1 Business Overview
8.13.2 Financial Data
8.13.3 Product Landscape
8.13.4 Strategic Outlook
8.13.5 SWOT Analysis
